Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$9.38 USD
-0.34 (-3.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $9.45 +0.07 (0.75%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth B Momentum D VGM
Earnings News For DTIL
-
Precision BioSciences (DTIL) Reports Q4 Loss, Lags Revenue Estimates
-
Precision BioSciences: Q4 Earnings Snapshot
-
Precision BioSciences: Q4 Earnings Snapshot
-
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
-
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
-
Precision BioSciences: Q3 Earnings Snapshot
-
Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Precision BioSciences to Report Third Quarter Results on November 7, 2023
-
Precision BioSciences (DTIL) Reports Q2 Loss, Tops Revenue Estimates
-
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Precision BioSciences to Report Second Quarter Results on August 4, 2023
-
Precision BioSciences: Q1 Earnings Snapshot
-
Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates
-
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
-
Precision BioSciences (DTIL) Reports Q4 Loss, Tops Revenue Estimates
-
Precision BioSciences: Q4 Earnings Snapshot
-
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
-
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2022 Results on March 9, 2023
-
Precision BioSciences (DTIL) Reports Q3 Loss, Tops Revenue Estimates
-
Precision BioSciences: Q3 Earnings Snapshot
-
Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Precision BioSciences (DTIL) Reports Q2 Loss, Misses Revenue Estimates
-
Precision BioSciences: Q2 Earnings Snapshot
-
Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Precision BioSciences (DTIL) Reports Q1 Loss, Misses Revenue Estimates